Evaluation of in vivo and in vitro Biological Activity of a Vibrio Cholerae 01 Hemolysin

Galindo, José Arellano; Angeles, Maria Guadalupe Rodriguez; Guadarrama, Norma Velazquez; Esteban, Enrique Santos; Cerezo, Silvia Giono
December 2007
Clinical & Investigative Medicine;Dec2007, Vol. 30 Issue 6, pE250
Academic Journal
Purpose: To evaluate the hemolysin effect by ileal loop model produced by Vibrio cholerae O1 strains, compared with the cellular lysis or cytotoxic activity (CA) observed in cell culture. Method: We studied nine V. cholerae O1 strains, obtained during the Mexican outbreak of cholera (1990-1993), which had CA in Vero and CHO cells. Hemolysin was monitored with the hemolysis test. Titers of CA were calculated by CD50, and the association between CA and cholera toxin (CT) production was discarded by means of neutralization tests using an anti-CT polyclonal antibody. The CT production was measured with ELISA test. The LAL assay was performed in order to study relationships between the CA and bacterial lipopolysaccharide. Strains with CA were evaluated in rabbit and rat ileal loop models; hemorrhagic fluid was also measured. Tissues from ileal loop were included in paraffin to detect intestinal epithelial damage. Results: The hemolysin CA was not neutralized with the anti-CT polyclonal antibody. However, the associated factor of CA was heat labile. CA in cell cultures was not related to the bacterial lipopolysaccharide. The ileal loop test exhibited the presence of hemorrhagic tissue with inflammation. Conclusion: The V. cholerae O1 strains isolated were able to secrete hemolysin which, in turn, caused CA in cell cultures and produced the hemorrhagic and inflammatory effects observed in the ileal loop of rabbit and rat models.


Related Articles

  • The First Appearance of Classical-like Phenotype Vibrio cholerae in Nepal. Pun, Sher Bahadur // North American Journal of Medical Sciences;Apr2014, Vol. 6 Issue 4, p183 

    A letter to the editor is presented in response to the article about a study the appearance of Vibrio cholerae strains that were found to be of the El Tor phenotype but carrying the classical cholera toxin in Nepal.

  • Immunobiological relationships between Vibrio fluvialis and Vibrio cholerae enterotoxins. Ahsan, C. R.; Sanyal, S. C.; Zaman, A.; Neogy, P. K. B.; Huqt, M. I. // Immunology & Cell Biology;Jun1988, Vol. 66 Issue 3, p251 

    A total of 26 strains of Vibrio fluvialis was included in this study. which were isolated from patients with diarrhoea and other sources. The GM1 enzyme linked immunosorbent assays performed with the culture filtrates of V. fluvialis yielded negative results, indicating that their receptor site...

  • Detection of Virulence Genes in Vibrio cholerae Isolated from Aquatic Environment in Kerala, Southern India. Praveen Kumar; Wilson Peter; Sabu Thomas // Applied Biochemistry & Biotechnology;Dec2008, Vol. 151 Issue 2/3, p256 

    Abstract   Vibrio cholerae is the etiologic agent of cholera. It is an autochthonous inhabitant of all aquatic environments. The virulence of V. cholerae is maintained by the CTX genetic element and tcpA gene. In the present investigation, environmental strains of V. cholerae...

  • © INTESTINAL ANTIBODIES IN RATS FOLLOWING EXPOSURE TO LIVE VIBRIO CHOLERAE. Cooper, G.N.; McNab, Christine; Walker, Patricia G.; Jackson, G.D.F. // Australian Journal of Experimental Biology & Medical Science;Aug1984, Vol. 62 Issue 4, p465 

    Investigates the intestinal antibodies in rats following exposure to live Vibrio cholerae. Determination of immunoglobulin concentrations; Transfer of serum antibodies to intestinal mucus; Use of indirect enzyme-linked immunosorbent assay methods.

  • Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes. Ebrahimizadeh, Walead; Mousavi Gargari, Seyedlatif; Rajabibazl, Masoumeh; Safaee Ardekani, Leila; Zare, Hamed; Bakherad, Hamid // Applied Microbiology & Biotechnology;May2013, Vol. 97 Issue 10, p4457 

    Vibrio cholerae is considered one of the major health threats in developing countries. Lack of efficient vaccine, short incubating time of the disease, and bacterium ability to survive in aquatic environment have made cholera one of the most epidemic diseases yet known. The lipopolysaccharide is...

  • Evaluation of TcpF-A2-CTB Chimera and Evidence of Additive Protective Efficacy of Immunizing with TcpF and CTB in the Suckling Mouse Model of Cholera. Price, Gregory A.; Holmes, Randall K.; Roop II, Roy Martin // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    The secreted colonization factor, TcpF, which is produced by Vibrio cholerae 01 and 0139, has generated interest as a potential protective antigen in the development of a subunit vaccine against cholera. This study evaluated immunogenicity/protective efficacy of a TcpF holotoxin-like chimera...

  • Combination of Salermide and Cholera Toxin B Induce Apoptosis in MCF-7 but Not in MRC-5 Cell Lines. Salahshoor, Mohammad Reza; Dastjerdi, Mehdi Nikbakht; Jalili, Cyrus; Mardani, Mohammad; Khazaei, Mozafar; Darehdor, Ahmad Shabanizadeh; Valiani, Ali; Roshankhah, Shiva // International Journal of Preventive Medicine;Dec2013, Vol. 4 Issue 12, p1402 

    Background: Sirtuin1 is an enzyme that deacetylates histones and several non-histone proteins including P53 during the stress. P300 is a member of the histone acetyl transferase family and enzyme that acetylates histones. Hereby, this study describes the potency combination of Salermide as a...

  • Rapid transient expression of cholera toxin B subunit (CTB) in Nicotiana benthamiana. Rattanapisit, Kaewta; Bhoo, Seong; Hahn, Tae; Mason, Hugh; Phoolcharoen, Waranyoo // In Vitro Cellular & Developmental Biology Plant;Apr2013, Vol. 49 Issue 2, p107 

    Cholera toxin B subunit (CTB) has the potential to be an effective adjuvant for mucosal vaccines because of its ability to increase antigen uptake and presentation by antigen-presenting cells through GM1-ganglioside binding. CTB has been produced using different recombinant protein expression...

  • Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen. Sugan Qiu; Xiaonan Ren; Yinyin Ben; Yanqin Ren; Jing Wang; Xiaoyan Zhang; Yanmin Wan; Jianqing Xu // Journal of Immunology Research;2014, p1 

    Previous study showed that CTB (Cholera toxin subunit B) can be used as a genetic adjuvant to enhance the systemic immune responses. To further investigate whether it can also be used as a genetic adjuvant to improve mucosal immune responses, we constructed DNA and recombinant Tiantan vaccinia...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics